why are glp-1 medications so expensive National Academy of Medicine | changing the conversation about obesity, but what does the evidence really say? Drugs like Ozempic, Wegovy, and Understanding the Real Cost of

Zaczek Z, Jurczak-Kobus P, Panczyk M, Braszczynska-Sochacka J, Majewska K, Kunecki M, et al

Regional Analysis North America Leading the GLP-1 Receptor Agonist Market North America accounted for the largest revenue share of 49.7% , supported by the high prevalence of type 2 diabetes and obesity, a developed healthcare system, and favorable reimbursement structures

According to the UK SmPC, Ozempic is typically initiated at 0.25 mg weekly for four weeks, then increased to 0.5 mg weekly, with potential further escalation to 1 mg weekly and then 2 mg weekly if needed for additional glycaemic control and if tolerated

twice-daily injection with fixed stepwise dosing

Without prebiotic fiber, without polyphenol-rich foods, without adequate dietary diversity, the probiotic strains cannot thrive or produce the metabolites that drive GLP-1 production